Investigating the influence of gut microbial metabolism on normal age-related cognitive decline
Lead Research Organisation:
University of Southampton
Department Name: Human Development and Health
Abstract
Cognition is a mental process for gaining knowledge and understanding of the world around us, and it usually gets worse with age. This deterioration often coincides with structural and functional changes in the brain. While healthy lifestyles can reduce the rate of age-associated cognitive decline, obesity has been implicated in its acceleration. This is important as obesity rates continue to rise in the UK, peaking in adults aged 45-54 years (36% obese) and remain high in older groups (33.5%, 55-74 years).
A vast population of microorganisms are present in the human gut, collectively referred to as the gut microbiota. We, and others have shown that these microorganisms are able to produce chemicals in the gut that can modify processes occurring in the brain with implications for cognition and overall well-being. Importantly, the types of microbes present in the gut and their overall activities change with age and obesity, and we now have preliminary data suggesting that the intestinal microbiota and their chemical output is related to normal age-related cognitive decline.
To further investigate this, we will measure the chemicals produced by the gut microbiota in humans of different ages and body mass index (BMI; a measure of obesity) and explore relationships between these signals and brain structure and function. Using different analytical chemistry techniques, we will measure microbial-related molecules in blood and stool samples collected from over 1,000 people (aged 50-98 years). These participants have had their brain structure and function measured as well as the microorganisms present in their stools (reflective of their gut microbiota). This data will allow us to identify microbial metabolites that are associated with brain function, the microorganisms responsible for their production, and the influence of age and obesity on their production and effects.
To confirm these findings, we will measure these same chemical messengers in blood and stool samples from a second set of individuals (181 in total; aged 23-66 years) whose brain function and gut microbiota has also been determined. These individuals have provided two samples one year apart with some samples provided by obese participants before and after weight loss. This data will allow us to confirm our initial findings in a separate group of people, assess the stability of microbial signals within the same individual, and the impact of obesity and weight loss on their production.
Finally, the processes through which these microbial metabolites affect brain structure and function will be studied in rodents. Here, rats will receive these chemicals and their cognitive functions will be assessed and specific brain processes will be measured. This will provide detailed information that will advance our understanding of how intestinal microorganisms can influence normal age-related cognitive decline. This will guide the development of strategies aimed at preserving a healthy microbiota (for example, high-fibre diets, prebiotics and probiotics) during ageing and in the presence of obesity to help reduce this decline.
A vast population of microorganisms are present in the human gut, collectively referred to as the gut microbiota. We, and others have shown that these microorganisms are able to produce chemicals in the gut that can modify processes occurring in the brain with implications for cognition and overall well-being. Importantly, the types of microbes present in the gut and their overall activities change with age and obesity, and we now have preliminary data suggesting that the intestinal microbiota and their chemical output is related to normal age-related cognitive decline.
To further investigate this, we will measure the chemicals produced by the gut microbiota in humans of different ages and body mass index (BMI; a measure of obesity) and explore relationships between these signals and brain structure and function. Using different analytical chemistry techniques, we will measure microbial-related molecules in blood and stool samples collected from over 1,000 people (aged 50-98 years). These participants have had their brain structure and function measured as well as the microorganisms present in their stools (reflective of their gut microbiota). This data will allow us to identify microbial metabolites that are associated with brain function, the microorganisms responsible for their production, and the influence of age and obesity on their production and effects.
To confirm these findings, we will measure these same chemical messengers in blood and stool samples from a second set of individuals (181 in total; aged 23-66 years) whose brain function and gut microbiota has also been determined. These individuals have provided two samples one year apart with some samples provided by obese participants before and after weight loss. This data will allow us to confirm our initial findings in a separate group of people, assess the stability of microbial signals within the same individual, and the impact of obesity and weight loss on their production.
Finally, the processes through which these microbial metabolites affect brain structure and function will be studied in rodents. Here, rats will receive these chemicals and their cognitive functions will be assessed and specific brain processes will be measured. This will provide detailed information that will advance our understanding of how intestinal microorganisms can influence normal age-related cognitive decline. This will guide the development of strategies aimed at preserving a healthy microbiota (for example, high-fibre diets, prebiotics and probiotics) during ageing and in the presence of obesity to help reduce this decline.
Technical Summary
We aim to determine the influence of gut microbial metabolism on normal age-related cognitive decline. Our recent preliminary work in humans identified gut microbial species, processes and metabolites related to cognitive functions that were negatively correlated with age and BMI. We have shown that several microbial metabolites that change with age and obesity are involved in the gut-brain axis. However, the role of gut microbial metabolism in normal age-related cognitive decline has not been comprehensively studied in humans and causality has not yet been established. The influence of obesity on this relationship also remains to be defined.
To investigate this, an initial discovery phase will leverage banked plasma and faecal samples from a large cross-sectional human study where cognition has been found to be inversely correlated with age and BMI (>1,000 participants [50-98 years]). A combination of high-resolution untargeted (NMR spectroscopy-based) and targeted (mass spectrometry-based) metabolomic approaches will be used to measure a broad range of metabolic features associated with gut microbial metabolism. Integrative multivariate data analysis techniques will be used to combine this metabolic data with existing shotgun metagenomic, brain structure and function data to identify microorganism-function-metabolite relationships related to cognitive decline. Candidate microbial metabolites will be validated using samples from an independent longitudinal study (181 individuals; 23-66 years) with accompanying metagenome, brain structure and function data. The longitudinal nature of this study also enables the stability of microbial metabolites to be evaluated over a one-year period, including in obese individuals before and after weight loss. Finally, rodent models will be used to demonstrate causality and understand the biomolecular mechanisms contributing to cognitive decline. This work will comprehensively address the research question posed.
To investigate this, an initial discovery phase will leverage banked plasma and faecal samples from a large cross-sectional human study where cognition has been found to be inversely correlated with age and BMI (>1,000 participants [50-98 years]). A combination of high-resolution untargeted (NMR spectroscopy-based) and targeted (mass spectrometry-based) metabolomic approaches will be used to measure a broad range of metabolic features associated with gut microbial metabolism. Integrative multivariate data analysis techniques will be used to combine this metabolic data with existing shotgun metagenomic, brain structure and function data to identify microorganism-function-metabolite relationships related to cognitive decline. Candidate microbial metabolites will be validated using samples from an independent longitudinal study (181 individuals; 23-66 years) with accompanying metagenome, brain structure and function data. The longitudinal nature of this study also enables the stability of microbial metabolites to be evaluated over a one-year period, including in obese individuals before and after weight loss. Finally, rodent models will be used to demonstrate causality and understand the biomolecular mechanisms contributing to cognitive decline. This work will comprehensively address the research question posed.
Publications
Caspani G
(2022)
Microbe-Immune Crosstalk: Evidence That T Cells Influence the Development of the Brain Metabolome.
in International journal of molecular sciences
Diaz Heijtz R
(2022)
Targeting microbial metabolites to treat autism.
in Nature medicine
Letertre M
(2022)
Characterizing the metabolic effects of the selective inhibition of gut microbial ß-glucuronidases in mice
in Scientific Reports
Penny HA
(2022)
Rhythmicity of intestinal IgA responses confers oscillatory commensal microbiota mutualism.
in Science immunology
Salminen S
(2022)
Author Correction: Reply to: Postbiotics - when simplification fails to clarify.
in Nature reviews. Gastroenterology & hepatology
Salminen S
(2022)
Author Correction: The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics
in Nature Reviews Gastroenterology & Hepatology
Swann JR
(2023)
Characterizing the metabolomic signature of attention-deficit hyperactivity disorder in twins.
in Neuropharmacology
Zuffa S
(2023)
Early-life differences in the gut microbiota composition and functionality of infants at elevated likelihood of developing autism spectrum disorder
in Translational Psychiatry
Description | Defined 'Postbiotics' a group of microbial modulators targeted at the gut microbiome |
Geographic Reach | Multiple continents/international |
Policy Influence Type | Citation in other policy documents |
Impact | Was involved in a task-force recruited by the International Scientific Association for Probiotics and Prebiotics (ISAPP) to define postbiotics - a group of strategies aimed and inducing favourable alterations in microbial-host interactions to improve host health. This has a significant impact on the field of gastrointestinal microbiology and defines the criteria against which food companies develop postbiotics. |
Description | Wrote an article for GPs detailing the importance of considering the gut microbiota in drug therapy |
Geographic Reach | National |
Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
URL | https://www.gponline.com/viewpoint-understanding-gut-microbiome-impact-drugs/article/1787621 |
Description | Characterising the impact of the gut microbiota and their metabolites on tau phenotypes in a Drosophila model - ARUK South Coast Network pump priming grants 2022 |
Amount | £3,000 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 01/2023 |
End | 04/2023 |
Description | EPIGENETIC-GENETIC-MENTAL HEALTH CASCADE BASED PERSONALISED PREVENTION OF NON-COMMUNICABLE DISEASE IN AUTISTIC ADOLESCENTS (ETHEREAL) |
Amount | £2,000,000 (GBP) |
Funding ID | UKRI supported UK research |
Organisation | European Research Council (ERC) |
Sector | Public |
Country | Belgium |
Start | 11/2022 |
End | 10/2027 |
Description | Understanding how food and beverages deliver improved nutrition across the lifecourse |
Amount | £1,900,000 (GBP) |
Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
Sector | Public |
Country | United Kingdom |
Start | 11/2022 |
End | 10/2025 |
Description | Amritpal Mudher - Drosophila models |
Organisation | University of Southampton |
Department | PublicPolicy@Southampton |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | I provide expertise on nutrition, metabolomics, and the microbiota to develop the drosophila model. |
Collaborator Contribution | Amritpal Mudher provides the infrastructure and expertise on the drosophila models |
Impact | We secured funding from Alzheimers Research UK to develop a drosophila model to study the gut-brain axis. |
Start Year | 2022 |
Description | Marianne Schultzberg |
Organisation | Karolinska Institute |
Country | Sweden |
Sector | Academic/University |
PI Contribution | Following on from my research in the microbiota-gut-brain axis field I was approached by Prof Schultzberg to perform metabolomics on studies she has conducted investigating the role of the intestinal microbiota in Alzheimer's disease and treatment responses. |
Collaborator Contribution | Professor Schultzberg's team perform rodent studies using mouse models of Alzheimer's disease and provides my research team with biological samples to explore the influence of the microbiota. |
Impact | Submitted a grant application to the BrightFocus Foundation exploring the gut microbial contribution to Alzheimer's disease development. |
Start Year | 2021 |
Description | Ragnar Klein Olsen |
Organisation | University of Copenhagen |
Country | Denmark |
Sector | Academic/University |
PI Contribution | I was approached by Ragnar Klein Olsen who wanted to spend time in my laboratory being trained in metabolomics and microbiomics with a specific focus on the gut-brain axis. Ragnar is a psychiatrist from Denmark. Ragnar spent 3 months working in the laboratory analysing data from a human study he had completed in Denmark exploring the use of prebiotics to reduce depression-associated fatigue. |
Collaborator Contribution | Ragnar completed a human study and brought data with him to analyse at Southampton. The findings will be written up as a manuscript for submission to a peer-reviewed journal. |
Impact | This is multidisciplinary. Ragnar is a psychiatrist who provides expertise in psychiatry and I provide expertise on metabolomics and the microbiome. |
Start Year | 2022 |
Description | Invited talk at the Netherlands Metabolomics Group annual meeting held in collaboration with DSM |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Delivered an invited talk to the annual meeting of the Netherland's metabolomics group held in collaboration with DSM - a leading ingredients company. The talk was focused on using metabolomics to study the gut microbiota-host metabolic interactions and their implications for host health. |
Year(s) Of Engagement Activity | 2022 |
Description | Nestle Education workshop on the Microbiota |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Undergraduate students |
Results and Impact | Designed and recorded teaching material for an online course providing information on the gut microbiota, malnutrition and its role in the gut-brain axis. This was in collaboration with Nestle and was aimed and a varied audience mainly based in LMIC countries. |
Year(s) Of Engagement Activity | 2022,2023 |
Description | Oral presentation at Mind, Mood, and Microbes virtual event |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Delivered an online presentation to the Mind, Mood and Microbes bridging event. This was one of eight presentations followed by an online Q&A session. This was well attended by researchers (>500) working within the gut-brain axis field. |
Year(s) Of Engagement Activity | 2023 |
URL | https://www.mindmoodmicrobes.org |
Description | Parliamentary Breakfast |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Policymakers/politicians |
Results and Impact | This was a cross-party Parliamentary Breakfast held at the House of Commons. It was led the Chair of the Environment, Food and Rural Affairs Committee, Sir Robert Goodwill MP. It marked the launch of new research, conducted by Kellogg's, into fibre and gut health across the UK. The goal is to emphasise the need to improve gut health in the UK by increasing dietary fibre intake across the population. |
Year(s) Of Engagement Activity | 2023 |
Description | Participated in the University of Southampton-BBSRC gut-brain-immunology workshop |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | Attended and contributed a talk to a workshop on the microbiota-gut-brain-immunology axis held by the University of Southampton and supported by funds from the BBSRC. This workshop brought together researchers from the south coast (Southampton, Bournemouth, Portsmouth, Canterbury) working in this area to develop collaborations for future grant applications |
Year(s) Of Engagement Activity | 2023 |
Description | Plenary lecture at the Nordic Metabolomics Society |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Invited to give the plenary talk at the Nordic Metabolomics Society annual meeting in Copenhagen. It was attended by a broad audience related to metabolomics research and this talk focused on the metabolic interactions between the microbiome and the mammalian host. |
Year(s) Of Engagement Activity | 2022 |
Description | Plenary talk at the International Society for Nutritional Psychiatry Research |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Plenary talk at the annual ISNPR scientific meeting in Cairns Australia |
Year(s) Of Engagement Activity | 2023 |
URL | https://icmsmeetings.eventsair.com/isnpr-2023/ |
Description | Virtual talk for 'Science' journal online |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Provided an online talk on the gut microbiota for the Science webinar series. This is popular webinar series with a broad global reach. I was contacted by individuals after the talk about potential collaborations. |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.science.org |